We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

An individual holding up a a sign that reads: "Climate justice now!"

World's Incomes to Fall By 19% by 2050 Due to Climate Change

Enhanced scanning electron microscopy (SEM) image of cancer malignant cells with high magnification of the cells surface

Cancer Cells’ Shapeshifting Ability Reveals New Drug Targets

An orange and brown butterfly on a green leaf.

Amazonian Butterfly a Result of Two Species Hybridizing 200,000 Years Ago

The Human Microbiome and Aging: What’s the Latest Research?

Cannabinols Show Neuroprotective Properties in Fruit Flies

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

IBN Engineers World's First Tri-Continuous Mesoporous Silica

The tri-continuous mesoporous material is the most complex mesoporous nanostructure to have been synthesized in real-life.

IDBS Wins Innovation in Business at Surrey Business Awards 2009

The award based on the continued success of its data management solutions and improvements in research data management.

Malvern Moves to Direct Support for Viscotek Products in India

Users of Viscotek GPC/SEC systems in India are taking advantage of enhanced customer support managed by Malvern Aimil Instruments Pvt Ltd.

Nature Publishes Pre-Clinical Data on an Inhibitor of a Novel Target Discovered by Millennium

The article describes the discovery of MLN4924a small molecule inhibitor of the NEDD8-Activating Enzyme.

New Medications Show Promise in Treating Drug-Resistant Prostate Cancer

A new therapy shows considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.

Prospectus for First European Microfluidics Consortium Announced

The consortium is aimed to facilitate the uptake of microfluidics in commercial applications.

Psivida Corp. Reports Iluvien™ Phase III Studies for DME

Data Safety Monitoring Board recommends the continuation of two pivotal Phase III clinical trials for the use of Iluvien™.

Exercise is Safe, Improves Quality of Life in Patients with Chronic Heart Failure

Regular exercise is safe for heart failure patients and may slightly lower their risk of death or hospitalization, NHLBI study finds.

Johns Hopkins University Deploys Proteus for Lab and Scientific Data Management Solution

The University will utilize GenoLogics’ Proteus to investigate the proteomics of adaptation to ischemia and hypoxia.

Oncolytics Announces Positive Results of Phase II REOLYSIN® and Radiation Combination Clinical Trial

The U.K. Phase II trial showed the objective tumor response rate of REOLYSIN® in combination with low-dose radiation in patients with advanced cancers.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter